Dr. Novack gave a lecture at the Kellogg Eye Center of the School of Medicine at the University of Michigan. The topic was “Contaminated Eye Drops: What is going on”? He described the ongoing issue with contamination and infection, what to do for patients, and the impact of this issue on the larger field of ophthalmic pharmaceuticals.
Dr. Gary Novack is a board-certified clinical pharmacologist and President of PharmaLogic Development with more than 40 years of experience in ophthalmic drug development, clinical research, and FDA regulatory strategy.
He has consulted for over 100 pharmaceutical and medical device companies and authored more than 400 scientific publications.